Drug search by name

Ertugliflozin and Hypoglycemia

Result of checking the interaction of drug Ertugliflozin and disease Hypoglycemia for safety when used together.

Check result:

Ertugliflozin <> Hypoglycemia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Ertugliflozin is a sodium glucose co-transporter-2 (SGLT2) inhibitor. The concomitant use of ertugliflozin with insulin and insulin secretagogues (e.g., sulfonylurea) may increase the risk of hypoglycemia. It is recommended to use caution and a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with ertugliflozin.

Ertugliflozin

Generic Name: ertugliflozin

Brand Name: Steglatro

Synonyms: n.a.

What is Ertugliflozin?